Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and similar GLP-1 medications have transformed weight loss treatment by reducing appetite and improving metabolic control. However, patients often ask whether rapid weight reduction comes at the cost of muscle mass—a valid concern, since preserving lean tissue is essential for long-term health and metabolic function. The good news: muscle loss during semaglutide treatment is manageable with the right approach.
How Semaglutide Affects Muscle During Weight Loss
When the body loses weight quickly, it doesn't always distinguish between fat and muscle tissue. Semaglutide works by slowing stomach emptying and activating GLP-1 receptors in the brain, which reduces hunger and calorie intake. If calorie deficit becomes too severe, the body may break down muscle for energy—a process called catabolism. Research shows that 25-40% of weight lost without resistance training can come from lean mass rather than pure fat.
The muscle-sparing effect depends heavily on individual factors. Age, baseline fitness level, genetic predispositions (which PlexusDx's Precision Peptide Genetic Test can identify), and adherence to strength training all influence whether your body preserves muscle during semaglutide therapy. Studies of GLP-1 recipients who maintained regular strength exercise reported significantly better lean mass retention than sedentary participants.
The Role of Protein Intake in Muscle Preservation
Adequate protein consumption is the single most important nutritional factor for maintaining muscle mass on semaglutide. During calorie restriction, your muscles require sufficient amino acids to prevent breakdown. Current evidence recommends 0.7–1.0 grams of protein per pound of target body weight daily for individuals undergoing weight loss therapy. This higher intake signals your body to preserve existing muscle tissue rather than metabolize it for fuel.
Many semaglutide patients experience reduced appetite, making protein targets challenging. Distributing protein evenly across meals—rather than concentrating it in one sitting—optimizes muscle protein synthesis throughout the day. High-quality sources like lean meats, fish, eggs, Greek yogurt, and legumes deliver the complete amino acid profile your muscles need to stay intact during treatment.
Strength Training as Your Muscle-Preservation Strategy
Resistance exercise is the most powerful tool for combating muscle loss during semaglutide therapy. When you challenge your muscles with progressive weight training, you send a signal to your body that muscle tissue is essential—worth preserving even during a calorie deficit. Studies comparing semaglutide recipients with and without strength programs show that exercisers retained 80–90% of their lean mass, while sedentary participants lost 30–50% of muscle alongside fat.
A practical strength routine doesn't require hours at a gym. Three to four sessions per week of compound movements—squats, deadlifts, chest presses, and rows—lasting 30–45 minutes each is sufficient. Progressive overload matters: gradually increasing weight or repetitions ensures your muscles remain challenged and signals the body to retain them. This combination of semaglutide, protein intake, and resistance training creates the optimal environment for fat loss while preserving muscle.
PlexusDx Support for Your Personalized Weight Loss Strategy
PlexusDx's compounded semaglutide injection (starting at $149/month) provides the same active medication as brand-name options, delivered through licensed 503A compounding pharmacies across all 50 states. Your personalized dosing is managed by PlexusDx clinicians who monitor your progress and adjust your protocol to balance weight loss speed with lean mass preservation—ensuring your dose can increase if needed without your price increasing.
For patients seeking deeper insights into their metabolic and muscle-preservation potential, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month). This test evaluates 14 metabolic pathways and 49 peptide-related genes—including variants in GLP1R, GIPR, FTO, and MC4R—revealing your genetic predispositions for muscle preservation, metabolic efficiency, and response to GLP-1 therapy. Understanding your unique genetic profile allows you to tailor protein intake, exercise timing, and medication dosing for maximum lean mass protection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide directly cause muscle loss?
Semaglutide itself doesn't directly destroy muscle tissue. Rather, rapid weight loss from reduced calorie intake can trigger muscle breakdown if protein intake and resistance training are insufficient. With proper nutrition and exercise, muscle loss is preventable.
How much muscle do people typically lose on semaglutide?
Without intervention, 25–40% of weight loss may be lean mass. However, patients who maintain adequate protein intake (0.7–1.0 g per pound of target weight) and perform regular strength training retain 80–90% of their muscle while losing predominantly fat.
Can I start semaglutide treatment without a gym membership?
Yes. PlexusDx serves all 50 states with no membership fees, and semaglutide injections start at $149/month with HSA/FSA eligibility. Strength training can be done at home with minimal equipment. Your PlexusDx clinician will help you design a realistic protocol.
What does the PlexusDx Precision Peptide Genetic Test reveal about muscle?
The test evaluates variants in genes like FTO and MC4R that influence metabolic rate, appetite regulation, and muscle-preservation capacity. These insights help personalize your protein targets, exercise approach, and semaglutide dosing for optimal lean mass retention.
Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic for weight loss?
PlexusDx's compounded semaglutide injection contains the same active ingredient and is dispensed by licensed 503A compounding pharmacies. Clinical efficacy is equivalent when dosing is properly managed. Your price stays flat at $149/month regardless of dose increases—ensuring cost-effective, uninterrupted treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Do You Lose on Wegovy in the First Month?
Navigating Your Ozempic Pen: A Guide to Safe and Effective Use for Your Weight Loss Journey